New Phase 2a data show the oral IPF therapy GRI-0621 modulates immune cell activity in adults with idiopathic pulmonary ...
The findings show that prolonged targeted therapy in patients with head and neck cancer can heighten tumor alertness, ...
Hijacking the energy-producing organelles from immune cells seems to help tumours in mice to infiltrate lymph nodes.